iPS cells:technology the front line of treatment with
관리자
view : 354
IPS cell technology is an innovative invention that Japan boasts to the world. However, in order to realize its full potential, it is necessary to promote research and development from a global perspective in cooperation with researchers not only in Japan but all over the world.
This time, CMIC Holdings Co., Ltd. will co-host the symposium "iPS Cell: The Front Line of Technology and Treatment" with NEXEL Co., Ltd., a world leader in iPSC (Artificial Pluripotent Stem Cell) technology.In order to acquire the expertise of researchers and R&D companies and improve their R&D capabilities, this symposium will give lectures to experts at home and abroad on the latest trends, ethics, guidelines and standardization of iPS cell technology.
We look forward to your participation.
Summary of the event
※The program is subject to change depending on the situation.Thank you for your understanding.
| Symposium Name | iPS cells : the forefront of technology and treatment |
|---|---|
| Time | September 6, 2023 (Wen) Lecture meeting 13:20-17:30 （12:30 Start accepting applications） Social gathering 17:30-19:00 |
| Venue | CMIC Group Headquarters 22F L&D1 Room Hamamatsucho Building, Shibaura 1-1-1 Minato Ward, Tokyo Access map |
| Object | Researchers interested in iPS cell technology, healthcare professionals, business people, media people, etc |
| Program |
■Session 1 13:20-15:00 |
| Participation Fee | Free of charge *Pre-registration is required. |
| How to participate | Please fill out the application form and apply. Register here |
| Host | CMIC Holdings Co., Ltd / NEXEL Co., Ltd. |
●Inquiries regarding this matter
CMIC Seminar Secretariat